tldrdailynews.com logo

Lilly’s 2026 deals widen biotech funding to more than 50 venture investors

1 min read
Source: Endpoints News
Lilly’s 2026 deals widen biotech funding to more than 50 venture investors
Photo: Endpoints News
TL;DR Summary

Eli Lilly's 2026 dealmaking has broadened the pool of early-stage funding for biotech startups, benefiting more than 50 venture investors and reinjecting capital into the startup ecosystem.

Topics:business#biotech#business#eli-lilly#life-sciences#startups#venture-capital
Share this article
  1. Lilly’s dealmaking spreads the wealth among a broad set of biotech venture investors  Endpoints News
  2. Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026  Endpoints News
  3. Lilly adds to immune drug pipeline with $2.9B Merida buyout  BioPharma Dive
  4. Eli Lilly (LLY) Makes a $2.88 Billion Autoimmune Bet. What Could Go Right or Wrong?  Yahoo Finance
  5. Lilly to buy Merida Biosciences for up to $2.875B in cash (LLY:NYSE)  Seeking Alpha

Reading Insights

Total Reads

1

Unique Readers

3

Time Saved

0 min

vs 1 min read

Condensed

69%

86 → 27 words

Want the full story? Read the original article

Read on Endpoints News